CARSGEN-B(02171),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

02171 CARSGEN-B

Not Yet Opened 01-22 16:08:18

15.870

+0.220

+1.41%

High16.600	Low15.660	Vol1.10M
Open15.740	D1 Closing15.650	Amplitude6.01%
Mkt Cap9.05B	Tradable Cap9.05B	Total Shares570.00M
T/O17.75M	T/O Rate0.19%	Tradable Shares570.00M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"02171","market":"HK","secType":"STK","nameCN":"CARSGEN-B","latestPrice":15.87,"timestamp":1769069298005,"preClose":15.65,"halted":0,"volume":1100300,"delay":0,"changeRate":0.014057507987220373,"floatShares":570000000,"shares":570000000,"eps":-1.6153929118853418,"marketStatus":"Not Yet Opened","change":0.22,"latestTime":"01-22 16:08:18","open":15.74,"high":16.6,"low":15.66,"amount":17751057,"amplitude":0.060064,"askPrice":15.87,"askSize":500,"bidPrice":15.86,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-1.0620421569688558,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1769131800000},"marketStatusCode":0,"adr":0,"listingDate":1623945600000,"exchange":"SEHK","adjPreClose":15.65,"openAndCloseTimeList":[[1769045400000,1769054400000],[1769058000000,1769068800000]],"volumeRatio":1.178304,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02171/tweets","defaultTab":"tweets","newsList":[{"id":"1111823522","title":"CARSGEN-B Surges Over 4% in Morning Session Following Recent Collaboration Announcement with Dispatch Bio","url":"https://stock-news.laohu8.com/highlight/detail?id=1111823522","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111823522?lang=en_us&edition=fundamental","pubTime":"2026-01-22 12:03","pubTimestamp":1769054587,"startTime":"0","endTime":"0","summary":"CARSGEN-B (02171) saw its shares climb 4.22% in the morning session, currently trading at HK$16.31, with a turnover of HK$7.3022 million. Recently, according to an announcement on the company's...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","BK1587","02171","BK1585"],"gpt_icon":0},{"id":"1176768425","title":"HK Stock Movement | CARSGEN-B (02171) Rises Nearly 4%, Recently Announced Collaboration with Dispatch Bio to Plan Related Clinical Trials for CT053","url":"https://stock-news.laohu8.com/highlight/detail?id=1176768425","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176768425?lang=en_us&edition=fundamental","pubTime":"2026-01-22 11:18","pubTimestamp":1769051898,"startTime":"0","endTime":"0","summary":"CARSGEN-B (02171) rose nearly 4%, and as of the time of writing, it was up 3.96%, trading at HK$16.27 with a turnover of HK$4.9417 million. Recently, according to a post on the company's official...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1585","BK1574","BK1161","BK1587","BK1610","02800","02171"],"gpt_icon":1},{"id":"2603261839","title":"Will Dispatch Bio CAR T Solid Tumor Trial Shift CARsgen Therapeutics' (SEHK:2171) Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2603261839","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603261839?lang=en_us&edition=fundamental","pubTime":"2026-01-14 18:25","pubTimestamp":1768386329,"startTime":"0","endTime":"0","summary":"In January 2026, Dispatch Bio and CARsgen Therapeutics announced a clinical collaboration in China to start a Phase 1 trial evaluating DISP-11, which combines Dispatch’s Flare platform and DV-10 virus with CARsgen’s approved BCMA-targeting CAR T therapy zevor-cel in patients with epithelial solid tumors.\nThis alliance is significant because it seeks to adapt a multiple myeloma CAR T-cell therapy for solid tumors, an area where immunotherapies have historically faced major biological...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/will-dispatch-bio-car-t-solid-tumor-trial-shift-carsgen-ther","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/will-dispatch-bio-car-t-solid-tumor-trial-shift-carsgen-ther","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","BK1161","CAR","LENZ","BK4007","BK1585","BK4022","BK4230","02171","BK1574","BK4539","BK1587"],"gpt_icon":0},{"id":"2602510676","title":"CARsgen Therapeutics Holdings Ltd:  Clinical Collaboration to Conduct a Phase 1 Trial in China, Planned to Begin in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2602510676","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602510676?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:05","pubTimestamp":1768223137,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nFWN3YD0SV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02171","BK1587","BK1585","BK1161","BK1574"],"gpt_icon":0},{"id":"2602151093","title":"CARsgen Therapeutics and Dispatch Bio launch clinical collaboration on solid tumor therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2602151093","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602151093?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:05","pubTimestamp":1768223122,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics Holdings Ltd. has announced a clinical collaboration with Dispatch Bio to evaluate the combination of Dispatch’s Flare platform and CARsgen’s zevorcabtagene autoleucel  in solid tumors. The planned Phase 1 trial, expected to begin in China in 2026, will investigate the use of Dispatch’s novel tumor-specific virus DV-10 followed by zevor-cel in patients with epithelial-origin solid tumors. This partnership aims to expand the application of CAR T-cell therapies to solid tumors, leveraging both companies’ innovative technologies and expertise.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CARsgen Therapeutics Holdings Ltd. published the original content used to generate this news brief via PR Newswire  on January 12,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nNDL4BLGy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1585","BK1161","BK1587","02171"],"gpt_icon":0},{"id":"2602583510","title":"CARsgen and Dispatch Bio Announce Clinical Collaboration to Evaluate Flare Platform and Zevor-Cel in Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2602583510","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602583510?lang=en_us&edition=fundamental","pubTime":"2026-01-12 21:05","pubTimestamp":1768223100,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nTUACHJYTX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1587","BK1574","BK1161","02171","BK1585"],"gpt_icon":0},{"id":"1132935236","title":"CARsgen-B (02171) Rises Nearly 6% on Inclusion of Solid Tumor Cell Therapy Project in National Major Scientific Project","url":"https://stock-news.laohu8.com/highlight/detail?id=1132935236","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132935236?lang=en_us&edition=fundamental","pubTime":"2026-01-05 11:25","pubTimestamp":1767583558,"startTime":"0","endTime":"0","summary":"CARsgen-B (02171) rose nearly 6%, and as of the time of writing, the stock was up 5.94% to HKD 16.23, with a turnover of HKD 18.8074 million. On December 30, the company announced through its...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","02171","BK1587","BK1161","BK1585"],"gpt_icon":0},{"id":"1139803283","title":"CARSGEN-B (02171) Repurchases 326,000 Shares for HK$4.8477 Million on December 29","url":"https://stock-news.laohu8.com/highlight/detail?id=1139803283","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139803283?lang=en_us&edition=fundamental","pubTime":"2025-12-29 21:24","pubTimestamp":1767014652,"startTime":"0","endTime":"0","summary":"CARSGEN-B (02171) announced that on December 29, 2025, the company repurchased 326,000 shares at a cost of HK$4.8477 million. The repurchase price ranged from HK$14.78 to HK$14.91 per share.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","02171","BK1585","BK1574","BK1161"],"gpt_icon":0},{"id":"2595673832","title":"CARsgen Therapeutics Repurchases 326,000 Shares for HKD 4.85 Million, Files Disclosure with HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2595673832","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595673832?lang=en_us&edition=fundamental","pubTime":"2025-12-29 21:19","pubTimestamp":1767014393,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics Holdings Ltd. has filed a Next Day Disclosure Return with the Hong Kong Stock Exchange, reporting recent changes in its issued shares. The filing details the total number of shares repurchased and the repurchase price per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CARsgen Therapeutics Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on December 29, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nNDL9Xvx3L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1585","BK1587","BK1574","02171"],"gpt_icon":0},{"id":"2595726302","title":"CARsgen Submits Dual IND Applications for Allogeneic BCMA CAR-T Therapy CT0596","url":"https://stock-news.laohu8.com/highlight/detail?id=2595726302","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595726302?lang=en_us&edition=fundamental","pubTime":"2025-12-29 08:10","pubTimestamp":1766967014,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CARsgen Therapeutics Holdings Ltd. published the original content used to generate this news brief via PR Newswire  on December 29, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nNDLbhYhVs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","02171","BK1587","BK1585"],"gpt_icon":0},{"id":"1134742148","title":"Non-Executive Director Guo Huaqing Increases Stake in CARSGEN-B (02171) by 30,000 Shares at HK$15.09 Per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=1134742148","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134742148?lang=en_us&edition=fundamental","pubTime":"2025-12-24 19:40","pubTimestamp":1766576418,"startTime":"0","endTime":"0","summary":"Latest data from the Hong Kong Stock Exchange shows that on December 19, Non-Executive Director Guo Huaqing purchased an additional 30,000 shares of CARSGEN-B (02171) at HK$15.09 per share, totaling...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1585","BK1161","02171","BK1587"],"gpt_icon":0},{"id":"1197161579","title":"HK Stock Buyback Summary | Dec 24","url":"https://stock-news.laohu8.com/highlight/detail?id=1197161579","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197161579?lang=en_us&edition=fundamental","pubTime":"2025-12-24 09:18","pubTimestamp":1766539098,"startTime":"0","endTime":"0","summary":"On December 23, 2025, multiple Hong Kong-listed companies conducted share buybacks. Among them, Tencent (00700) recorded the highest buyback amount, repurchasing 1.051 million shares for HKD 636...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00434","SG9999015978.USD","LU1960683339.HKD","LU1328615791.USD","00799","LU1642822792.SGD","LU0048597586.USD","IE00BPRC5H50.USD","LU1785774172.SGD","LU0650527681.SGD","LU0314109678.HKD","LU2399975544.HKD","LU0029875118.USD","06100","BK1608","LU2097828805.USD","LU1725190679.HKD","LU0882747503.HKD","LU0856984785.SGD","SG9999001846.SGD","SGXZ90724238.SGD","LU0708995583.HKD","BK1539","01024","GB00BDT5M118.USD","LU0348816934.USD","IE0001KFT4U8.USD","BK1517","LU0210527791.USD","LU0329678337.USD","LU1051768304.USD","LU1196710351.USD","LU1831875114.USD","LU1868837722.USD","09886","09923","LU0143863198.USD","LU2226246903.HKD","HK0000320223.HKD","BK1531","BK1149","BK1508","IE00BZ08YR35.GBP","LU0345775950.USD","LU0819123356.HKD","SG9999017495.SGD","LU0128522157.USD","LU1251922891.USD","SG9999006514.SGD","IE0008368411.USD","LU1733274390.USD","01583","BK1599","LU0244354667.USD","HK0000252160.HKD","LU0791590937.USD","LU2023250504.SGD","02392","SG9999004220.SGD","LU0683595622.HKD","LU0203345920.USD","09669","LU0509642566.USD","LU0287142896.SGD","LU0593848301.USD","LU0047713382.USD","BK1556","LU0261950983.USD","LU0633140727.USD","LU1196710195.USD","BK1515","02869","LU0499858602.USD","LU0501845795.SGD","SG9999014880.SGD","LU0348825331.USD","LU0608807433.USD","BK1613","IE00B5MMRT66.SGD","LU0594300419.USD","SG9999001093.SGD","BK1523","BK1549","IE00B0169N27.USD","00345","LU1188198961.HKD","LU1515016050.SGD","LU0675040207.SGD","LU0828238088.HKD","LU0577902454.USD","BK1518","LU1044876610.USD","SG9999000459.SGD","LU0049853897.USD","LU1861214812.USD","LU0985320562.USD","LU0072462343.USD","LU2237443622.USD","SG9999000418.SGD","81810","LU1196710864.SGD","LU0648948544.HKD","LU2152927971.USD","LU1226288253.USD","BK1189","BK1148","TCHmain","HXXD.SI","IE00BQXX3D17.EUR","IE00B543WZ88.USD","BK1597","SG9999004311.SGD","LU0651947912.USD","LU1769817096.USD","BK1619","LU0348783662.USD","LU2498475776.HKD","LU1282651121.HKD","LU0871576103.HKD","06826","LU1366334578.USD","LU3063872942.SGD","LU0880133367.SGD","LU1807302812.USD","01588","LU0823040885.USD","LU0531970944.HKD","IE00B8L5B284.USD","LU0328353924.USD","IE0034224299.USD","LU1282649141.HKD","02251","BK1586","LU0165289439.USD","02121","LU0164872284.USD","LU1102505762.USD","LU1794554557.SGD","BK1610","LU1951186391.HKD","SG9999002463.SGD","LU0149534421.HKD","LU0231483743.USD","LU0588545904.SGD","HK0000252152.HKD","81024","LU1861219969.SGD","LU1152091168.USD","LU0823041008.USD","BK1103","LU2778985437.USD","HK0000165453.HKD","BK1535","LU0862451753.SGD","LU0823039010.USD","IE00B031J352.USD","LU0708995153.HKD","LU1226287792.SGD","LU0502904849.HKD","LU0320764243.SGD","LU0572944931.SGD","02171","IE00B0169L03.USD","LU1720050803.USD","BK1155","LU1048484197.HKD","LU1655091459.SGD","LU1675838814.USD","GELYY","LU1282649810.SGD","LU1813983027.USD","LU1568876251.USD","EVS.SI","LU1981816686.USD","HTCD.SI","LU0791591158.USD","LU1804176565.USD","LU0456827905.SGD","LU0823426480.USD","LU1366334651.USD","LU0572939691.SGD","02018","LU0797268264.HKD","LU0577902538.SGD","LU1023057109.AUD","00175","BK1504","LU0348767384.USD","BK1618","LU0039217434.USD","LU2460026573.USD","BK1247","LU0588546209.SGD","LU1568876335.HKD","HK0000320264.USD","LU0823413587.USD","LU0819121731.USD","LU1105468828.SGD","LU1439102457.SGD","BK1110","LU2237443978.SGD","LU0972618739.USD","80175","LU1880383366.USD","LU1883866441.USD","LU0127658192.USD","LU0228659784.USD","LU0441854154.USD","LU1282648689.USD","SG9999015945.SGD","IE00BQXX3C00.GBP","IE0008368742.USD","LU1719994722.HKD","01458","LU0531971595.HKD","SG9999001069.SGD","LU0737861772.HKD","LU0449509016.USD","LU0320764599.SGD","BK1170","LU0348814723.USD","BK1590","LU1770034418.SGD","LU2051468812.USD","LU0516422366.SGD","09959","HK0000500386.USD","SG9999015986.USD","LU0307460666.USD","LU0072913022.USD","LU0048580855.USD","LU0651946864.USD","02367","LU0235996351.USD","LU2125910849.SGD","LU2293587155.HKD","LU0918141705.HKD","LU0251144936.SGD","LU0417516738.SGD","LU0359202008.SGD","IE0008369823.USD","LU0516422440.USD","SGXZ31699556.SGD","02598","BK1587","01907","01919","BK1500","LU0918141887.USD","BK1506","IE00B3M56506.USD","LU0348827113.USD","LU0823038988.USD","HK0000306701.USD","LU1226287875.USD","LU0414403682.SGD","LU0541501648.USD","LU0348766576.USD","SG9999015952.SGD","BK1593","BK1160","LU0396098781.USD","LU2087589342.USD","LU0259732245.USD","LU0886674414.USD","LU0700851271.USD","LU0269904917.USD","LU2097828474.EUR","SG9999002828.SGD","LU0561508036.HKD","BK1585","LU0084288322.USD","BK1591","00700","BK1612","LU2008162690.USD","LU2237443382.USD","LU0516423091.SGD","LU0164865239.USD","SG9999000327.SGD","SGXZ99366536.SGD","BK1237","LU1242518857.USD","LU0128522744.USD","LU2242644610.SGD","SG9999001689.USD","LU0642271901.SGD","02886","SG9999014674.SGD","LU1814569148.SGD","LU2362541273.HKD","LU0979878070.USD","LU1048588211.SGD","IE0003895053.USD","LU0784639295.USD","LU2133065610.SGD","LU0181495838.USD","LU0106959298.USD","LU0543330566.HKD","LU1328277881.USD","LU1974910355.USD","09857","LU0499858438.USD","LU2257852520.SGD","LU1733274473.HKD","LU2237443549.SGD","SG9999018857.SGD","BK1209","02419","LU0192582467.USD","LU1235295612.USD","BK1589","LU0821914370.USD","LU2279701549.SGD","LU1282651048.USD","LU1504937902.USD","LU0831103253.SGD","LU1226287529.USD","LU0541502299.USD","03888","LU0175139822.USD","IE00BZ08YT58.USD","BK1607","01672","LU0011963245.USD","LU0029874905.USD","IE00B067MR52.USD","SG9999013353.USD","LU2251237306.USD","LU1769817179.HKD","LU1044875133.USD","LU2360107325.USD","LU0143863784.USD","LU1211504680.USD","BK1615","BK1609","LU0149721374.USD","LU0890818403.SGD","08188","BK1117","SG9999001051.SGD","LU2247934214.USD","BK1229","LU0051755006.USD","LU0164880469.USD","LU0196878994.USD","LU0326948709.USD","LU0049112450.USD","SG9999007991.SGD","LU0054237671.USD","LU2449936058.SGD","LU2462611646.USD","IE00BGV7N243.SGD","LU1242518931.SGD","LU0828237510.HKD","LU0672654166.SGD","LU0577902298.EUR","SG9999001903.USD","BK1221","IE0009570106.USD","02416","IE0031814852.USD","LU0865486749.SGD","LU2237443465.HKD","BK1583","IE00B0JY6N72.USD","LU0264606111.USD","LU0061477393.USD","LU0320764755.SGD","LU0043850808.USD","LU0348735423.USD","LU0823413660.USD","BK1542","LU1051769294.HKD","LU0543330483.HKD","LU0052750758.USD","BK1574","LU0261947096.USD","SGXZ81514606.USD","LU1629966141.USD","00697","BK1142","LU0634319403.HKD","LU0898667661.SGD","LU0326950275.SGD","LU1282649067.USD","01317","LU1226288097.SGD","LU1316542783.SGD","LU0289960550.SGD","XIACY","IE00B97KM107.HKD","BK1521","BK1183","LU0173614495.USD","LU1048596156.SGD","BK1596","LU0607220059.USD","IE00BZ08YS42.EUR","LU0633140560.USD","BK1566","SG9999001226.SGD","LU0823397285.USD","IE0032834883.USD","LU0605514214.HKD","LU0106259558.USD","BK1526","LU0169518387.USD","LU0417516902.SGD","LU0823426308.USD","IE0003795394.USD","LU2039709279.SGD","BK1228","LU0431992006.USD","00947","LU0228367735.SGD","LU0345769128.USD","LU1770036033.HKD","SG9999014906.USD","01773","BK1104","HK0000306685.HKD","IE0032431581.USD","LU0577902371.SGD","LU0203347892.USD","SG9999003461.SGD","02167","LU0117841782.USD","01600","LU0348723411.USD","SG9999002562.SGD","BK1502","LU2362541513.USD","01651","LU2476274720.SGD","LU0348805143.USD","LU0315179316.USD","LU0516423174.USD","LU1046422090.SGD","LU0348788117.USD","BK1258","LU0828237940.HKD","LU0048388663.USD","LU2265009873.SGD","LU1868837565.USD","LU0370786039.SGD","LU1152091754.HKD","LU1323998911.USD","09878","LU0417516571.SGD","BK1575","LU1956131251.USD","01810","LU1993786604.SGD","LU2106854487.HKD","LU0589944569.HKD","LU0738912210.USD","LU1224444064.USD","SG9999014898.SGD","LU0608807946.USD","LU0588545490.SGD","LU1718418525.SGD","BK1161","LU0106252389.USD","LU0359201885.HKD","LU2362540622.SGD","LU0873338254.USD","LU2476274308.USD","LU1226288170.HKD","BK1505","LU0210533765.USD","LU0488056044.USD","BK1124","BK1216","01995","LU0210526637.USD","IE00BQXX3F31.USD","LU0348784397.USD","LU0345769631.USD","LU0096374516.USD","LU1439103000.SGD","LU0359201612.USD","BK1193","IE00BF5LJ272.USD","LU1008478684.HKD","BK1253","LU1734074674.USD","LU1810669033.SGD","LU0067412154.USD","LU2097828631.EUR","02038","LU1102505929.USD","LU0469268626.HKD","LU1808992512.USD","LU0878005551.USD","LU0117844026.USD","LU1917777945.USD","LU1303224171.USD","BK1095","LU0516422952.EUR","LU0540923850.HKD","IE00B031HY20.USD","LU0456846285.SGD","02219","LU0456842615.SGD","06868","SG9999018865.SGD","LU0329678170.USD","LU2045819591.USD","LU0107464264.USD","LU0345776255.USD","LU2488822045.USD","00314","09896","LU0455707207.USD","LU0293314216.USD","LU0868486357.SGD","LU0080751232.USD","LU0348783233.USD","LU0588545730.USD","LU0878004406.USD","LU1688375341.USD","LU2097828557.USD","LU0315178854.USD","SG9999006597.SGD","LU0823397103.USD","SG9999014914.USD","SGXZ51526630.SGD","BK1128","LU0737861699.HKD","LU0132412106.USD","LU0214875030.USD","BK1126","BK1604","LU1880383440.USD","LU0254981946.USD","BK1246","LU2177674079.SGD","LU0070217475.USD","IE00B29SXG58.USD","00909","BK1119","02678","LU2237443895.HKD","LU0862451837.USD","LU1481107354.HKD","LU0163747925.USD","LU0786609619.USD","LU1868838027.USD","00732","LU2317271919.USD","IE00B8HQ1Z84.USD","LU0463099449.HKD","LU2125910500.SGD","LU0327786744.USD","LU0054450605.USD","LU1961090484.USD","IE00B031HW06.USD","LU0594300179.USD","BK1249","LU0572940350.SGD","LU2097828714.EUR","LU1044874839.SGD","BK1167","LU0140636845.USD","SG9999001440.SGD","BK1516","LU0611395673.USD","BK1207","LU0211977185.USD","BK1109","LU0449515922.USD","LU0577902611.USD","LU2251237488.HKD","IE0003851619.USD","06078","LU1224709979.USD","LU0384037296.USD","02299","LU0229945570.USD","LU0188438112.USD","LU0211331839.USD"],"gpt_icon":1},{"id":"1188650112","title":"CARSGEN-B (02171) Repurchased 320,000 Shares for HK$4.8609 Million on December 23","url":"https://stock-news.laohu8.com/highlight/detail?id=1188650112","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188650112?lang=en_us&edition=fundamental","pubTime":"2025-12-23 21:20","pubTimestamp":1766496014,"startTime":"0","endTime":"0","summary":"CARSGEN-B (02171) announced that on December 23, 2025, the company repurchased 320,000 shares for HK$4.8609 million, with the repurchase price ranging between HK$14.98 and HK$15.25 per share.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","02171","BK1587","BK1161","BK1585"],"gpt_icon":0},{"id":"2593418319","title":"CARsgen Therapeutics Repurchases 320,000 Shares for HKD 4.86 Million in HKEX Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2593418319","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593418319?lang=en_us&edition=fundamental","pubTime":"2025-12-23 21:15","pubTimestamp":1766495739,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics Holdings Ltd. has filed a next day disclosure return with the Hong Kong Stock Exchange, announcing the repurchase of 320,000 ordinary shares at a total aggregate price of HKD 4,860,855. The repurchased shares will be held as treasury shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CARsgen Therapeutics Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on December 23, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nNDL1tyz8S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1587","BK1574","BK1585","BK1161","02171"],"gpt_icon":0},{"id":"1117143477","title":"Non-Executive Director Guo Huaqing Increases Stake in CARSGEN-B (02171) by 18,000 Shares at HK$14.52 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=1117143477","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117143477?lang=en_us&edition=fundamental","pubTime":"2025-12-22 19:30","pubTimestamp":1766403034,"startTime":"0","endTime":"0","summary":"Latest data from the Hong Kong Stock Exchange shows that on December 18, Non-Executive Director Guo Huaqing purchased an additional 18,000 shares of CARSGEN-B (02171) at HK$14.52 per share, totaling...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","02171","BK1585","BK1161","BK1587"],"gpt_icon":0},{"id":"2592498781","title":"Is BCMA CAR-T Catalogue Inclusion And Pipeline Progress Altering The Investment Case For CARsgen (SEHK:2171)?","url":"https://stock-news.laohu8.com/highlight/detail?id=2592498781","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592498781?lang=en_us&edition=fundamental","pubTime":"2025-12-20 19:14","pubTimestamp":1766229276,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics Holdings recently reported that its BCMA-targeted CAR-T therapy zevorcabtagene autoleucel was added to China’s new Commercial Health Insurance Innovative Drug Catalogue, while early clinical data for its allogeneic BCMA CAR-T candidate CT0596 were presented at the 67th ASH Congress with favorable tolerability and efficacy signals.\nTogether, these updates underline CARsgen’s progress across both approved and next-generation BCMA therapies, signaling broader potential...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/is-bcma-car-t-catalogue-inclusion-and-pipeline-progress-alte","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/is-bcma-car-t-catalogue-inclusion-and-pipeline-progress-alte","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2065732104.USD","CAR","BK1587","BK1574","BK1585","BK4097","BK4022","PRGS","BK1161","BK4230","02171"],"gpt_icon":0},{"id":"2592193243","title":"CARsgen Therapeutics Holdings (SEHK:2171): Valuation Check After Zevor‑cel Listing and New CT0596 Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2592193243","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592193243?lang=en_us&edition=fundamental","pubTime":"2025-12-19 18:31","pubTimestamp":1766140310,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics Holdings (SEHK:2171) just checked two important boxes for investors, with zevor cel entering China’s new Innovative Drug Catalogue and fresh CT0596 data showcased at the ASH congress.\nSee our latest analysis for CARsgen Therapeutics Holdings.\nEven with the share price sitting at HK$15.0 after a steep 90 day share price return of minus 28.77 percent and a softer 30 day share price return of minus 13.34 percent, the strong year to date share price return of 59.91 percent...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/carsgen-therapeutics-holdings-sehk2171-valuation-check-after","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-2171/carsgen-therapeutics-holdings-shares/news/carsgen-therapeutics-holdings-sehk2171-valuation-check-after","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","BK1587","02171","BK4139","BK1574","BK4539","BK4007","BK1585","LENZ"],"gpt_icon":0},{"id":"2592813282","title":"CARsgen Therapeutics Extends Share Repurchase Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2592813282","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592813282?lang=en_us&edition=fundamental","pubTime":"2025-12-19 11:36","pubTimestamp":1766115405,"startTime":"0","endTime":"0","summary":"CARsgen Therapeutics  extended a previously announced share repurchase program, according to a Hong Kong bourse filing Thursday.Shares of the cell therapy developer gained over 1% in morning trade Friday.The program will last until the company's next annual general meeting.CARsgen plans to repurchase a total of 5% of its issued share capital from the open market under the program.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","LENZ","BK1587","BK4139","BK4539","BK4007","BK1585","02171","BK1574"],"gpt_icon":0},{"id":"2592790764","title":"BRIEF-Carsgen Therapeutics Says Yijie Concert Group Purchased 335,000 Shares From November 6 To December 17","url":"https://stock-news.laohu8.com/highlight/detail?id=2592790764","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592790764?lang=en_us&edition=fundamental","pubTime":"2025-12-18 23:03","pubTimestamp":1766070225,"startTime":"0","endTime":"0","summary":"BRIEF-Carsgen Therapeutics Says Yijie Concert Group Purchased 335,000 Shares From November 6 To December 17Dec 18  - CARsgen Therapeutics Holdings Ltd 2171.HK:YIJIE CONCERT GROUP PURCHASED 335,000 SHARES FROM NOVEMBER 6 TO DECEMBER 17Further company coverage: 2171.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nFWN3XO0IG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02171","BK1574","BK1161","BK1587","BK1585"],"gpt_icon":0},{"id":"2592909739","title":"CARsgen Therapeutics - Yijie Concert Group Purchased 335,000 Shares From November 6 to December 17","url":"https://stock-news.laohu8.com/highlight/detail?id=2592909739","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592909739?lang=en_us&edition=fundamental","pubTime":"2025-12-18 21:42","pubTimestamp":1766065362,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251218:nFWN3XO0IG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","BK1585","BK1574","BK1587","02171"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.carsgen.com","stockEarnings":[{"period":"1week","weight":-0.0255},{"period":"1month","weight":0.033},{"period":"3month","weight":-0.0544},{"period":"6month","weight":-0.3533},{"period":"1year","weight":0.4201},{"period":"ytd","weight":0.0539}],"compareEarnings":[{"period":"1week","weight":-0.0154},{"period":"1month","weight":0.0304},{"period":"3month","weight":0.0238},{"period":"6month","weight":0.0471},{"period":"1year","weight":0.3222},{"period":"ytd","weight":0.0372}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"CARsgen Therapeutics Holdings Ltd is an investment holding company primarily engaged in discovering, researching and developing cell therapies. The Company’s main business is developing chimeric antigen receptor T cell (CAR T) -cell therapies to address clinical needs including but not limited to hematologic malignancies solid tumors and autoimmune diseases. The Company’s main products include zevor-cel (zevorcabtagene autoleucel), satricabtagene autoleucel and allogeneic CAR T-cell products. The Company mainly operates its businesses in China and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.07656},{"month":2,"riseRate":0.75,"avgChangeRate":0.310052},{"month":3,"riseRate":0,"avgChangeRate":-0.128154},{"month":4,"riseRate":0.25,"avgChangeRate":-0.092431},{"month":5,"riseRate":0.75,"avgChangeRate":0.085205},{"month":6,"riseRate":0.5,"avgChangeRate":0.033426},{"month":7,"riseRate":0.4,"avgChangeRate":-0.015336},{"month":8,"riseRate":0.6,"avgChangeRate":0.066197},{"month":9,"riseRate":0.4,"avgChangeRate":0.033481},{"month":10,"riseRate":0.6,"avgChangeRate":0.024843},{"month":11,"riseRate":0.6,"avgChangeRate":0.051023},{"month":12,"riseRate":0.4,"avgChangeRate":-0.058482}],"exchange":"SEHK","name":"CARSGEN-B","nameEN":"CARSGEN-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CARSGEN-B(02171),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest CARSGEN-B(02171) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"CARSGEN-B,02171,CARSGEN-B股票,CARSGEN-B股票老虎,CARSGEN-B股票老虎国际,CARSGEN-B行情,CARSGEN-B股票行情,CARSGEN-B股价,CARSGEN-B股市,CARSGEN-B股票价格,CARSGEN-B股票交易,CARSGEN-B股票购买,CARSGEN-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CARSGEN-B(02171),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest CARSGEN-B(02171) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}